Valuation: Asahi Kasei Corporation

Market Cap 2,154B 13.68B 11.93B 11.23B 10.23B 19.18B 1,310B 19.2B 135B 51.85B 668B 51.38B 50.24B P/E 2027 *
12.9x
P/E 2028 * 11.7x
Enterprise Value 2,802B 17.79B 15.51B 14.61B 13.31B 24.95B 1,704B 24.98B 175B 67.44B 868B 66.83B 65.35B EV / Sales 2027 *
0.86x
EV / Sales 2028 * 0.81x
Free-Float
96.19%
Yield 2027 *
2.82%
Yield 2028 * 3.07%
09-15 Asahi Kasei Bioprocess Unveils Vantij Su-Vfc Benchtop for Automated Single-Use Virus Filtration CI
09-14 Asahi Kasei Unit Starts Phase Two Study of Antifungal Cresemba for Pediatric Patients in Japan MT
08-26 Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company?s 40-Year North American Battery Separator Strategy CI
08-20 Asahi Kasei Develops Novel Lithium Pre-Doping Technology For Silicon-Rich Lithium-Ion Batteries CI
08-19 Asahi Kasei Expands Capacity For Water Electrolysis And Chlor-Alkali Equipment In Kawasaki CI
08-17 Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 5, 2025. CI
08-12 Asahi Kasei Corporation's Equity Buyback announced on November 5, 2025, has closed with 22,859,400 shares, representing 1.69% for ¥39,999.9 million. CI
08-06 Asahi Kasei Corporation and Highchem Shanghai Enter First License Agreement for Production and Sale of Acetolyte Novel Electrolyte in China CI
07-31 Asahi Kasei's Attributable Net Income Surges 173% in Fiscal Q1 MT
07-30 Asahi Kasei Corporation Provides Dividend Guidance for the End of Second Quarter of Fiscal Year Ending March 31, 2027 CI
07-30 Asahi Kasei Corporation Provides Consolidated Earnings Guidance for the Six Months and Fiscal Year Ending March 31, 2027 CI
07-30 Asahi Kasei Corporation Provides Dividend Guidance for the End of Fourth Quarter of Fiscal Year Ending March 31, 2027 CI
07-30 Asahi Kasei Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
1 week+3.62%
Current month+1.38%
1 month+3.34%
3 months-6.75%
6 months+8.24%
Current year+21.68%
1 week 8.78
Extreme 8.776
9.2
1 month 8.63
Extreme 8.634
9.24
3 years 5.62
Extreme 5.618
10.38
5 years 5.62
Extreme 5.618
10.38
10 years 5.25
Extreme 5.25
13.4
Manager TitleAgeSince
Director of Finance/CFO - -
President 67 2022-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 2022-03-31
Director/Board Member 79 2018-05-31
Director/Board Member 67 2021-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.90%+2.04%+35.01%+44.44% 13.72B
+1.42%+1.63%+26.17%+28.16% 69.24B
-0.50%-0.91%+19.94%+18.16% 50.96B
+0.07%+0.40%+3.22%+25.21% 16.68B
-0.74%+2.89%+34.79%+62.24% 13.72B
-2.30%+3.66%+34.32%+22.89% 10.29B
-1.10%-3.01%+16.01%-22.08% 9.92B
+0.78%-2.56%+14.06% - 9.04B
-2.41%-6.52%+90.82%-9.91% 8.68B
-0.63%+2.49%-13.37%+9.90% 7.91B
Average -0.60%-0.26%+26.10%+19.89% 21.83B
Weighted average by Cap. +0.05%+0.35%+24.56%+23.71%

Financials

2027 *2028 *
Net sales 3,263B 20.72B 18.06B 17.01B 15.49B 29.05B 1,985B 29.09B 204B 78.53B 1,011B 77.82B 76.1B 3,362B 21.35B 18.61B 17.53B 15.97B 29.94B 2,045B 29.97B 210B 80.93B 1,042B 80.2B 78.42B
Net income 168B 1.07B 931M 877M 799M 1.5B 102B 1.5B 10.5B 4.05B 52.12B 4.01B 3.92B 184B 1.17B 1.02B 959M 873M 1.64B 112B 1.64B 11.49B 4.43B 56.99B 4.39B 4.29B
Net Debt 648B 4.11B 3.59B 3.38B 3.08B 5.77B 394B 5.78B 40.46B 15.59B 201B 15.45B 15.11B 572B 3.63B 3.16B 2.98B 2.71B 5.09B 348B 5.09B 35.69B 13.76B 177B 13.63B 13.33B
Logo Asahi Kasei Corporation
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
Employees
-
Date Price Change
26-09-21 €9.094 +1.90%
26-09-18 €8.924 +0.04%
26-09-17 €8.920 +1.00%
26-09-16 €8.832 +0.64%
26-09-15 €8.776 0.00%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,600.00JPY
Average target price
1,963.33JPY
Spread / Average Target
+22.71%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!